23 and me is using its customers genetic data to try to become a new kind of pharma company. Can eight point eight million d an a spit tests add up to a cancer break through or just a privacy nightmare? This week's bloomburg business week comes from the financial capital of the world, Bloomburg.
This week's Cover Story for Bloomberg Businessweek:
'23andMe Wants to Use Its Customers’ Genetic Data to Beat Cancer'
Read by Bloomberg's Mark Leydorf
CEO Anne Wojcicki wants to make drugs using insights from millions of customer DNA samples, and doesn’t think that should bother anyone.
See omnystudio.com/listener for privacy information.